Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

  • Amelia Nur Vidyanti,
  • Lung Chan,
  • Cheng-Li Lin,
  • Chih-Hsin Muo,
  • Chung Y. Hsu,
  • You-Chia Chen,
  • Dean Wu,
  • Chaur-Jong Hu
  • Article
  • Metrics
  • Comments
  • Media Coverage

After publication of this article [1], the authors contacted PLOS ONE to clarify that they did not obtain prospective institutional review board approval to conduct their study. Upon editorial review and consultation with the Academic Editor, it was determined that the article meets the journal’s standards for ethical oversight and that approval by an ethics committee was not necessary given that all data analyzed in the study were fully anonymized prior to access and analysis by the authors.

In light of this update, the final two sentences of the second paragraph in the Study design and population subsection of the Materials and methods are incorrect. The correct sentence is: All data analyzed in the study were fully anonymized prior to access and analysis by the authors.

Reference

  1. 1. Vidyanti AN, Chan L, Lin C-L, Muo C-H, Hsu CY, Chen Y-C, et al. (2019) Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study. PLoS ONE 14(8): e0221750. https://doi.org/10.1371/journal.pone.0221750 pmid:31465467

Citation: Vidyanti AN, Chan L, Lin C-L, Muo C-H, Hsu CY, Chen Y-C, et al. (2020) Correction: Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study. PLoS ONE 15(4): e0232016. https://doi.org/10.1371/journal.pone.0232016

Published: April 15, 2020

Copyright: © 2020 Vidyanti et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.